RESUMEN
Waldenström macroglobulinemia (WM) and its associated hyperviscosity syndrome (HVS) are generally caused by lymphoplasmacytoid lymphoma or other small B-cell lymphoproliferative disorders. WM associated with extranodal marginal zone B-cell-mucosa-associated lymphoid tissue lymphoma (EMZL/MALT-type) has not been emphasized. We describe 4 men and 2 women (age, 40-79 years) with clinical and laboratory manifestations of WM and EMZL/MALT-type involving one or more sites: lung, pericardium/pleura, ocular adnexa, nasopharynx, minor salivary gland, glossopharyngeal fold, skin, and stomach. The following immunophenotypic patterns were observed: CD20+, 6; CD43+, 3; kappa light chain restriction, 5; and lambda light chain restriction, 1. All were negative for CD5, CD10, and cyclin D1 expression. A clonal paraproteinemia was present in each (IgM kappa, 4; IgM lambda, 1; biclonal IgM kappa/IgA kappa, 1). All 4 patients tested had elevated plasma viscosity; clinical HVS occurred in 3, and 2 required emergency plasmapheresis. These findings suggest that EMZL/MALT-type can cause WM and that the laboratory evaluation of EMZL/MALT-type should include serum protein electrophoresis/immunofixation, and plasma viscosity measurements and urine immunofixation in select cases. EMZL/MALT-type should be considered in the differential diagnosis in patients with clinicopathologic features of WM.
Asunto(s)
Linfoma de Células B de la Zona Marginal/complicaciones , Linfoma de Células B/complicaciones , Macroglobulinemia de Waldenström/etiología , Adulto , Anciano , Antígenos CD/análisis , Biomarcadores de Tumor/metabolismo , Viscosidad Sanguínea , Células Clonales , Femenino , Humanos , Inmunofenotipificación , Ganglios Linfáticos/patología , Linfoma de Células B/metabolismo , Linfoma de Células B/patología , Linfoma de Células B de la Zona Marginal/metabolismo , Linfoma de Células B de la Zona Marginal/patología , Masculino , Persona de Mediana Edad , Paraproteinemias , Macroglobulinemia de Waldenström/metabolismo , Macroglobulinemia de Waldenström/patologíaRESUMEN
Although the parotid is a target for myoepithelial sialadenitis and lymphomas of mucosa associated lymphoid tissue (MALTomas), MALTomas are rare and have not been well characterized in the cytology literature. We examine fine needle aspiration biopsies from 19 lymphoid lesions of the parotid gland with particular emphasis on MALTomas and their cytologic look-a-likes. Purely on cytology it is difficult to distinguish with certainty a MALToma from a late-phase reactive lymph node. Both conditions were predominantly composed of small mature appearing lymphocytes and both occasionally had larger lymphocytes with tingible body macrophages. By contrast, the diagnosis of non-MALT lymphoma was usually straight forward, as they had overt cytologic atypia. In applying fine needle aspiration biopsy to large or persistent lymphoid lesions of extra-nodal sites like the parotid gland, we recommend the liberal use of flow cytometric analysis to distinguish between reactive lymph nodes and MALToma and to more precisely classify non-MALT lymphomas.
Asunto(s)
Linfoma/diagnóstico , Membrana Mucosa/patología , Enfermedades de las Parótidas/diagnóstico , Neoplasias de la Parótida/diagnóstico , Seudolinfoma/diagnóstico , Adenolinfoma/diagnóstico , Adenolinfoma/patología , Biopsia con Aguja , Diagnóstico Diferencial , Humanos , Linfoma/complicaciones , Linfoma/patología , Enfermedades de las Parótidas/patología , Neoplasias de la Parótida/complicaciones , Neoplasias de la Parótida/patología , Seudolinfoma/complicaciones , Seudolinfoma/patología , Estudios RetrospectivosRESUMEN
Stromal tumors of the abdominal colon, the least common of all gastrointestinal stromal tumors, have not been well characterized. They have often been lumped with stromal tumors of the anorectum in order to achieve significant numbers for analysis, yet there are no data to prove that stromal tumors from these two sites are the same. In this study, we evaluated 20 colonic stromal tumors to identify clinical, morphologic, and immunophenotypic features that were useful in discriminating between those that had metastasized or caused death from those that had not metastasized or caused death. We found that colonic stromal tumors are morphologically heterogeneous, and the malignant ones are clinically aggressive. They often have metastases at presentation, and cause death in a short time. An infiltrative growth pattern in the muscularis propria, invasion of the mucosa, and high mitotic counts correlated significantly both with metastases and with death from tumor. We also found that dense cellularity correlated significantly with metastases, but not with death, and that coagulative necrosis correlated with death, but not with metastases.
Asunto(s)
Neoplasias del Colon/patología , Neoplasias de los Tejidos Blandos/patología , Células del Estroma/patología , Adulto , Anciano , Neoplasias del Colon/cirugía , Femenino , Humanos , Inmunohistoquímica , Inmunofenotipificación , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias de los Tejidos Blandos/cirugíaRESUMEN
Stromal tumors of the anorectum are a rare group of mesenchymal tumors that often have a protracted clinical course. We sought to determine which clinical, morphologic, and immunophenotypic features correlated with an adverse outcome in 22 patients with anorectal stromal tumors. An adverse outcome, defined as either tumor recurrence or metastasis, occurred in nine patients. Seven patients had metastases, two of whom also had local recurrences. Four of these patients also died from their disease. One patient had one local recurrence, and one patient had two local recurrences; neither of these patients had metastases. Recurrences were found as long as 103 months and metastases as late as 117 months after initial presentation. However, for patients without an adverse outcome, maximum follow-up was only 84 months. Thus both recurrence and metastasis may not appear until several years after treatment, indicating that a long-term follow-up period, probably longer than available for many tumors without an adverse outcome in this study, is needed before a patient can be considered to be cured. Tumor size greater than five centimeters correlated with an adverse outcome. However, given the protracted course of these tumors and the relatively limited follow-up available, other features such as location within the muscularis propria, mitotic activity, necrosis, and pleomorphism that did not significantly correlate with an adverse outcome may become significant with longer follow-up periods. We also found that on the basis of morphologic appearance and whether tumors were confined to the submucosa or located within the muscularis propria, anorectal stromal tumors could be divided into three groups, and that the behavior of anorectal stromal tumors may also depend upon their phenotype. The largest group of 17 tumors was located within the muscularis propria, mitotically active, and composed of densely cellular spindle-shaped cells. A second group of two tumors was also located within the muscularis propria and was composed of spindle-shaped cells, but lacked dense cellularity and mitotic activity. The third group was composed of three submucosal, polypoid tumors.
Asunto(s)
Neoplasias del Ano/patología , Neoplasias del Recto/patología , Neoplasias de los Tejidos Blandos/patología , Células del Estroma/patología , Adulto , Anciano , Neoplasias del Ano/cirugía , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias del Recto/cirugía , Neoplasias de los Tejidos Blandos/cirugía , Análisis de SupervivenciaRESUMEN
PURPOSE: Preclinical studies show a significant increase in the ratio of the radiosensitizer bromodeoxyuridine (BUdR) in tumors versus the intestinal mucosa during the drug elimination period, compared with the ratio during drug infusion. We constructed a phase I study in patients with locally advanced cervix cancer, using alternating cycles of BUdR and radiation therapy (RT). PATIENTS AND METHODS: Eighteen patients with stage IIB to IVA cervix cancer participated. A treatment cycle consisted of a 4-day BUdR infusion followed by a week of pelvic RT, 15 Gy twice daily in 1.5-Gy fractions. After three cycles, additional BUdR was infused, followed by brachytherapy. The fraction of thymidine replaced by BUdR and the fraction of cells incorporating BUdR were determined in rectal mucosa and tumor biopsies at the end of the first BUdR infusion (day 5), at the middle of the first RT week (day 10), and at the time of brachytherapy. RESULTS: Dose-limiting toxicity was observed in one of 16 patients receiving 1,000 mg/m2/d x 4 days and in both patients receiving 1,333 mg/m2/d x 4 days each cycle. After a median follow-up of 39 months, 12 patients (66%) were free of pelvic disease and nine (50%) were alive and disease free. The ratio of tumor to rectum BUdR incorporation averaged 1.5 to 1.8 and did not differ significantly between day 5 and day 10. A trend toward reduced ratio was observed at brachytherapy. Drug-containing cells in rectal biopsies migrated from the crypts to the mucosal surface. CONCLUSION: In this schedule, 1,000 mg/m2/d is the maximum-tolerated dose of BUdR. BUdR incorporation levels in tumors were consistent with clinically significant radiosensitization. The migration of BUdR-containing rectal mucosa cells from the crypts to the surface at the time of RT suggests that this regimen may offer a relative sparing of the mucosa from radiosensitization.
Asunto(s)
Bromodesoxiuridina/administración & dosificación , Fármacos Sensibilizantes a Radiaciones/administración & dosificación , Neoplasias del Cuello Uterino/radioterapia , Adenocarcinoma/radioterapia , Adenocarcinoma/secundario , Adulto , Anciano , Biopsia , Braquiterapia , Bromodesoxiuridina/efectos adversos , Bromodesoxiuridina/farmacocinética , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/secundario , Supervivencia sin Enfermedad , Femenino , Humanos , Mucosa Intestinal/metabolismo , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Fármacos Sensibilizantes a Radiaciones/efectos adversos , Fármacos Sensibilizantes a Radiaciones/farmacocinética , Dosificación Radioterapéutica , Tasa de Supervivencia , Neoplasias del Cuello Uterino/metabolismo , Neoplasias del Cuello Uterino/mortalidad , Neoplasias del Cuello Uterino/patologíaRESUMEN
Small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), and SLL plasmacytoid (SLLP) are malignant neoplasms of small B cells that may have overlapping cytologic features. Entities such as SLL with irregular nuclear contours may pose additional diagnostic difficulties. We investigated the utility of flow cytometric analysis and immunohistochemistry studies in distinguishing these disorders from each other. We reviewed 29 lymphomas and classified them as SLL (13 cases), MCL (8 cases), and SLLP (8 cases) based on histology and expression of cytoplasmic immunoglobulin light chain. Paraffin section immunohistochemistry was performed for CD5, CD20, CD23, CD43, CD45RA, CD45RO, and kappa and lambda light chains. Flow cytometric analysis was carried out by 2-color direct immunofluorescence for CD5, CD11c, CD19, CD20, CD22, CD23, FMC7, and kappa and lambda light chains. By immunohistochemistry, we found that the expression of CD23 in SLL discriminates between SLL and MCL and that the expression of CD23 and CD43 in SLL discriminates between SLL and SLLP. By flow cytometric analysis, we found that CD11c+ and dim fluorescence intensity of slg and dim fluorescence intensity of FMC7 in SLL distinguish SLL from MCL, and the expression of CD5+, CD23+ and dim fluorescence intensity of FMC7 in SLL distinguishes SLL from SLLP. We found no immunophenotypic difference between SLL and SLL with irregular nuclear contours.
Asunto(s)
Citometría de Flujo , Inmunohistoquímica , Leucemia Linfocítica Crónica de Células B/diagnóstico , Linfoma no Hodgkin/diagnóstico , Diagnóstico Diferencial , Técnica del Anticuerpo Fluorescente , Humanos , Cadenas kappa de Inmunoglobulina/análisis , Cadenas lambda de Inmunoglobulina/análisis , Inmunofenotipificación , Leucemia Linfocítica Crónica de Células B/patología , Linfoma no Hodgkin/patología , ParafinaRESUMEN
We retrospectively studied the usefulness of intraoperative cytology (IOC) and frozen section (FS) in the rapid diagnosis of 68 thyroid lesions. In 14 cases of papillary thyroid carcinoma, IOC correctly diagnosed 13 cases, while FS correctly diagnosed 11 cases. There was no significant difference in sensitivities, and both methods had similar specificities. In 21 cases of colloid nodule, IOC was slightly more sensitive than FS; IOC correctly diagnosed 16 cases, while FS correctly diagnosed 15 cases. However, the specificity of IOC was only 71%, but was 98% for FS. Of 17 follicular adenomas, FS diagnosed 16 as follicular neoplasms and misdiagnosed only 1 as a colloid nodule. By contrast, IOC misdiagnosed 9 follicular adenomas as colloid nodules, most of which were macrofollicular variants with abundant colloid. Of 11 follicular carcinomas, FS diagnosed all as follicular neoplasms, while IOC misdiagnosed 3 as colloid nodules. While IOC is not as accurate as FS in the diagnosis of colloid nodules and follicular neoplasms, it is highly sensitive and specific in the diagnoses of papillary carcinoma and performance of the technique is rapid and easy. In an intraoperative setting, IOC is a useful adjunct to FS in screening thyroid nodules for the presence of papillary carcinoma.
Asunto(s)
Secciones por Congelación , Cuidados Intraoperatorios , Enfermedades de la Tiroides/diagnóstico , Glándula Tiroides/patología , Biopsia , Carcinoma Papilar/diagnóstico , Humanos , Estudios Retrospectivos , Neoplasias de la Tiroides/diagnóstico , Nódulo Tiroideo/diagnóstico , Tiroidectomía , Tiroiditis Autoinmune/diagnósticoAsunto(s)
Enfermedad Veno-Oclusiva Hepática/etiología , Trasplante de Riñón/efectos adversos , Adulto , Femenino , Enfermedad Veno-Oclusiva Hepática/diagnóstico por imagen , Enfermedad Veno-Oclusiva Hepática/patología , Enfermedad Veno-Oclusiva Hepática/cirugía , Humanos , Hígado/patología , Trasplante de Hígado , Pielonefritis/cirugía , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVE: The objective of this study was to describe the mammographic appearance with pathologic correlation of metaplastic carcinoma of the breast. CONCLUSION: Metaplastic carcinomas of the breast are masses with mammographic characteristics of low suspicion because of their histologic appearance. Metaplastic carcinoma should be included in the differential assessment of predominately circumscribed, noncalcified masses revealed on mammography. One salient feature that may distinguish metaplastic carcinomas is the occurrence of a circumscribed portion with a spiculated portion, which is seen in carcinomas that have a significant mixture of metaplastic and invasive carcinoma growth patterns.
Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/secundario , Carcinoma/diagnóstico por imagen , Carcinoma/secundario , Mamografía , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/patología , Carcinoma/patología , Femenino , Humanos , Persona de Mediana Edad , Estudios RetrospectivosAsunto(s)
Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/secundario , Neoplasias Meníngeas/patología , Meningioma/diagnóstico , Meningioma/secundario , Biopsia con Aguja , Femenino , Humanos , Neoplasias Pulmonares/química , Neoplasias Pulmonares/patología , Neoplasias Meníngeas/química , Meningioma/química , Meningioma/patología , Persona de Mediana Edad , Mucina-1/análisis , Recurrencia Local de Neoplasia/química , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/patología , Vimentina/análisisRESUMEN
Gastrointestinal stromal tumors (GISTs), as currently defined, are mesenchymal tumors of the gastrointestinal tract composed of spindled and/or epithelioid stromal cells that are neither mature Schwann cells nor smooth muscle cells. Many studies have lumped GISTs from all gut sites, when in fact these tumors differ histologically by location. In this study, we evaluated a set of parameters by both univariate and multivariate analysis to determine which parameters correlated with metastases in 36 GISTs from the jejunum and ileum, exclusively. The parameters included organoid architecture, cellularity, mitotic counts, epithelioid cell shape, mucosal invasion, tumor size, skeinoid fibers, nuclear pleomorphism, ischemic necrosis, immunohistochemical differentiation, and proliferating cell nuclear antigen labeling. We evaluated these retrospectively without knowledge as to the metastatic outcome of the tumors. By univariate analysis, dense cellularity, mitotic counts, epithelioid cell shape, mucosal invasion, and size were statistically significant correlates with metastases. By multivariate analysis, only dense cellularity and mitotic counts were independent correlates with metastases. Whether these features are useful predictors of behavior remains to be tested.